The most common adverse effects are chest pain, hypotension, injection site pain, abdominal pain, nausea, vomiting, minor hemorrhage, gross hematuria, and backache.

Rare but severe side effects include thrombocytopenia, anaphylaxis, major hemorrhage (cerebrovascular, pulmonary), and non-hemorrhagic cerebrovascular accident.

Abciximab administration is not associated with a higher risk of bleeding in those undergoing CABG treatment.

Pregnancy category C risk has not been ruled out. Infant risk during breastfeeding has not had research performed to date.